#EULAR2023 – eular 23 – Social Media Analytics and Transcripts
The aim of the European Congress of Rheumatology is to provide a forum of the highest standard for scientific (both clinical and basic), educational and
Related Articles
P152 Very Late Onset Systemic Lupus Erythematosus – Comparison with Younger Patients
AbstractBackground/Aims. Age has a significant impact on SLE. However, data on very late onset SLE (vlSLE) patients are scarce. We have characterized a lar
British Societies Develop First ‘Living’ Behçet Guidelines
The British Society for Rheumatology and the British Association of Dermatologists developed guidelines for the management of people living with Behçet’s disease.
Frontiers | Heterogeneity of macrophage activation syndrome and treatment progression
Macrophage activation syndrome (MAS) is a rare complication of autoimmune inflammatory rheumatic diseases (AIIRD) characterized by a progressive and life-thr…
US FDA approves Boehringer Ingelheim’s high-concentration, citrate-free formulation of Cyltezo® (adalimumab-adbm) injection
/PRNewswire/ — Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has approved the high-concentration, citrate-free…
Approaches for slowing organ damage progression in lupus | RheumNow
Watch our videos featuring global rheumatology experts to learn about recent advances towards slowing organ damage progression in lupus. Discover how you can implement disease…
Interleukin‑18 binding protein: Biological properties and roles in human and animal immune regulation (Review)
IL-18 binding protein (IL-18BP) is a natural regulatory molecule of the proinflammatory cytokine IL-18. It can regulate activity of IL-18 by high affinity binding. The…
CAR T-Cell Therapy in Autoimmune Disease | NEJM
To the Editor: In the case series presented by Müller et al. (Feb. 22 issue),1 CD19-targeting chimeric antigen receptor (CAR) T-cell therapy in patients with…
Biomarker Predictors of Osteoarthritis | RheumNow
Science Advances has reported that Duke University researchers have validated a biomarkers of osteoarthritis that may be identified 2 years before the appearance of radiographic…
ARCTIC Rewind: Can You Taper DMARDs with Remission? | RheumNow
In an open-label, randomized, non-inferiority trial, rheumatoid arthritis patients in remission were subject to tapering of disease-modifying antirheumatic drugs (DMARDs), and while maintenance of remission…
P152 Very Late Onset Systemic Lupus Erythematosus – Comparison with Younger Patients
AbstractBackground/Aims. Age has a significant impact on SLE. However, data on very late onset SLE (vlSLE) patients are scarce. We have characterized a lar